Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHRM.L Regulatory News (PHRM)

  • There is currently no data for PHRM

Board Changes

25 Feb 2015 07:02

RNS Number : 7836F
Phorm Corporation Limited
25 February 2015
Β 

25 FebruaryΒ 2015

Β 

PhormΒ CorporationΒ Limited

("Phorm"Β orΒ theΒ "Company")

Β 

BoardΒ Changes

Β 

PhormΒ (AIM:Β PHRM),Β aΒ leadingΒ internetΒ personalisationΒ technology company,Β announcesΒ thatΒ Mr Lex Fenwick is being appointed as a Non-Executive Director of the Company and that Lord Lamont has resigned.

Β 

BoardΒ Changes

Phorm is pleased to announce that Mr Lex Fenwick will be appointed as a Non-Executive Director of the Company on 1 March 2015. Mr Fenwick is former CEO of Dow Jones & Co. and former CEO of Bloomberg L.P. Mr Fenwick brings with him invaluable experience from international finance, data and media businesses. Phorm also announces that Lord Lamont has resigned from the Board with immediate effect.

Β 

Β 

KentΒ Ertugrul, Chairman andΒ CEOΒ ofΒ Phorm, commented:

"We are delighted to welcome Lex to the Phorm Board. As a world-class CEO his experience will be of huge value as the business moves into the next stage of its development, generating large scale commercial revenue in major markets. We would also like to take this opportunity to thank Lord Lamont for his advice and support over the last 6 years and wish him well for the future."

Β 

Lex FenwickΒ commented:

"I am extremely excited to be joining the board of Phorm at a pivotal stage in its development. I have been watching the business for a considerable period of time and I look forward to helping them scale and reach their commercial potential."

Β 

AdditionalΒ informationΒ onΒ MrΒ Lex Fenwick

TheΒ following additionalΒ information is providedΒ inΒ accordance withΒ paragraph (g)Β ofΒ Schedule TwoΒ toΒ theΒ AIM RulesΒ forΒ Companies:

Β 

Alexius ("Lex") John Benedict FenwickΒ (aged 55)

Β 

Current Directorships/Partnerships Β 

Past Directorships/Partnerships (last 5 years)

Selector Consultancy LLC

Dow Jones & Co.

Bloomberg L.P.

Bloomberg Inc.

Bloomberg Communications Inc.

Bloomberg SP Inc.

Bloomberg (GP) Finance LLC

Skillman Business Park LLC

Bloomberg T-Book Inc.

731 Funding LLC

Bloomberg Korea LLC

Bloomberg Finance Germany LLC

Bloomberg Ventures LLC

BLP Consulting Services Ltd.

Bloomberg New Zealand

Bloomberg Korea Ltd.

Bloomberg Data Services (India) Private Limited

BFM Financial Research Ltd.

Bloomberg Venezuela SRL

Bloomberg Bermuda Limited

Bloomberg Telecommunications Pte Ltd.

Bloomberg U.K. Limited

Bloomberg Value-Added Network Services South Africa (Proprietary) Limited

Bloomberg Chile Limitada

Β 

ThereΒ isΒ no otherΒ informationΒ thatΒ isΒ required toΒ beΒ disclosedΒ pursuantΒ toΒ paragraphΒ (g)Β ofΒ ScheduleΒ TwoΒ toΒ theΒ AIMΒ RulesΒ forΒ Companies.

Β 

Β 

-Ends-

ForΒ furtherΒ informationΒ pleaseΒ contact:Β PhormΒ CorporationΒ Limited

AndyΒ CroxsonΒ (analystsΒ andΒ investors) +44Β (0)Β 203Β 397Β 6001

Β 

UKΒ Investors

MirabaudΒ SecuritiesΒ LLPΒ (Broker) +44 (0) 207 321Β 2508

JasonΒ WoollardΒ PeterΒ Krens

Β 

StrandΒ HansonΒ LimitedΒ (NominatedΒ Adviser) +44 (0) 207 409Β 3494

JamesΒ HarrisΒ MatthewΒ ChandlerJamesΒ Dance

Β 

USΒ Investors

Lippert/HeilshornΒ and AssociatesΒ (InvestorΒ Relations) Β +1Β 212Β 838Β 3777

JohnΒ Heilshorn

Β 

AboutΒ Phorm

Phorm is a global personalisation technology company that makes content and advertising more relevant Β tothe consumer. Phorm'sΒ innovativeΒ platformΒ preservesΒ userΒ privacyΒ andΒ delivers aΒ moreΒ interestingΒ onlineΒ experience.

Β 

Phorm'sΒ Β industryΒ Β leading technology enablesΒ Β itsΒ Internet Service ProviderΒ ("ISP")Β partners to offer aΒ newΒ typeΒ ofΒ onlineadvertisingΒ platformΒ andΒ aΒ freeΒ consumerΒ internetΒ contentΒ feature,Β ensuringΒ moreΒ relevantΒ advertisementsΒ andΒ personalised content forΒ opted-in users.

Β 

Phorm'sΒ  advertising platform revolutionises current standardsΒ ofΒ onlineΒ privacy,Β fullyΒ protectingΒ theΒ identityΒ ofΒ consumers.Phorm's solution Β isΒ Β completelyΒ Β Β opt-in. OnlyΒ Β those usersΒ Β consenting toΒ Β theΒ Β service areΒ Β profiledΒ Β and onlyΒ Β ever onΒ anΒ anonymousΒ basis.

Β 

Phorm'sΒ partnersΒ includeΒ leading ISPs,Β Publishers, Advertising NetworksΒ and Advertisers.

Β 

Phorm,Β underΒ a Β predecessorΒ holding company, was admitted to the Β AIMΒ marketΒ of the LondonStockΒ ExchangeΒ inΒ 2004.

Β 

ForΒ moreΒ information, pleaseΒ visit:Β www.phorm.com

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
BOATAMMTMBJTMPA
Date   Source Headline
14th Apr 201610:00 amRNSUpdate and Resignation of Nominated Adviser
16th Mar 201612:37 pmRNSIssue of US$500,000 of Convertible Loan Notes
16th Mar 20167:00 amRNSIssue of US$500,000 of Convertible Loan Notes
25th Feb 20168:02 amRNSFunding Update and Statement re Suspension
25th Feb 20167:55 amRNSSuspension - Phorm Corporation Limited
4th Feb 20166:05 pmRNSFunding Update
1st Feb 20163:49 pmRNSSubscription Update, New Subscription & Loan
21st Jan 20167:00 amRNSPhorm Awarded TRUSTe Certified Privacy Seal
18th Jan 20167:00 amRNSSubscription & Operational Update
5th Jan 20162:00 pmRNSTR-1: Notification of major interest in shares
23rd Dec 20151:00 pmRNSRevised Non-Executive Director Compensation
22nd Dec 20157:00 amRNSDirectorate Change
7th Dec 20157:00 amRNSRepricing of Options
3rd Dec 201511:00 amRNSPhorm Enables Hover Rate with Insomnis Media
1st Dec 20157:00 amRNSNew Share Option Plan and Grant of Options
18th Nov 20157:00 amRNSTR-1: Notifications of Major Interests in Shares
28th Oct 20157:00 amRNSPartnering Agreement with INSOMNIS Media Limited
20th Oct 20157:00 amRNSAgreement with Causemo, Inc.
13th Oct 20157:00 amRNSPhorm Hires Chief Revenue Officer
9th Oct 20157:00 amRNSAgreement with Boston Globe Media Group
30th Sep 20151:33 pmRNSInterim Results
28th Aug 20152:38 pmRNSResult of AGM
10th Aug 20157:00 amRNSNotice of Annual General Meeting
7th Aug 20157:48 amRNSEquity fundraising of approximately £3.2 million
29th Jul 20157:02 amRNSUpdate re Board Changes
28th Jul 20157:00 amRNSLoan Agreement & Convertible Loan Note Extension
15th Jul 201511:21 amRNSBoard and Management Changes
3rd Jul 20157:00 amRNSOperational Update
2nd Jul 20157:16 amRNSDirectorate Change
30th Jun 20157:00 amRNSAnnual Financial Report
8th May 20154:00 pmRNSTR-1: Notification of major interest in shares
22nd Apr 20157:00 amRNSEquity Fundraising of £6.0 million Gross
21st Apr 20154:22 pmRNSOperational Update
16th Mar 20153:45 pmRNSDirectorate Change
25th Feb 20157:02 amRNSBoard Changes
19th Jan 20157:00 amRNSEquity fundraising of approximately £6.25 million
16th Jan 20157:21 amRNSOperational Update
8th Dec 20147:00 amRNSEquity Fundraising
28th Oct 20147:00 amRNSTR-1: Notification of major interest in shares
8th Oct 20147:00 amRNSEquity fundraising of £4.47 million
6th Oct 20147:00 amRNSOperational Update
22nd Aug 20147:05 amRNSSubscription To Raise £2.4 million
22nd Aug 20147:00 amRNSInterim Results
24th Jul 20142:31 pmRNSResult of Annual General Meeting
27th Jun 20147:30 amRNSGlobal Operations Update
27th Jun 20147:05 amRNSNotice of Annual General Meeting and Board Changes
27th Jun 20147:00 amRNSFinal Results for the Year Ended 31 December 2013
23rd Apr 20144:25 pmRNSTR-1: Notification of major interest in shares
14th Apr 201412:40 pmRNSResult of EGM
27th Mar 20147:00 amRNSProposed £10m Placing & Notice of EGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.